Bird & Bird advises InGeneron on divestment of Eticur GmbH

Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.



Headquartered in Houston and Munich, InGeneron is a privately held company that was formed to innovate cell-based technologies for healthcare and life sciences research. Eticur has been one of the leading providers of high-quality testing, processing and storage of stem cells from the umbilical cord.

The following Bird & Bird lawyers advised InGeneron: Partner Stefan Münch and Associate Daniel Gloor (both Corporate/M&A, Munich).


News & Deals

More News & Deals

News

Bird & Bird continues sponsoring Slush Investor Day, reinforcing commitment to Nordic tech investment

Sep 13 2024

Read More

News

Bird & Bird’s Aviation team in Asia-Pacific ranks 2nd in AFG Legal Survey

Sep 12 2024

Read More

Deal

Bird & Bird has advised East Japan Railway Company in the sale of Decorum Vending Limited

Sep 11 2024

Read More

Deal

Bird & Bird advised Capital Croissance on its investment in Aether FS

Sep 09 2024

Read More

Deal

Bird & Bird acts as sell-side legal advisor to Vitruvian Partners on its sale of Benify

Sep 06 2024

Read More

Deal

Bird & Bird advise Leo Capital on launching their first Nordic Fund

Sep 05 2024

Read More